论文部分内容阅读
目的:对女性尿路感染采用莫西沙星与加替沙星治疗的临床疗效的分析比较。方法:选取2012年9月~2013年6月在我院确诊为尿路感染的女性患者160例,随机将患者分为莫西沙星治疗组和加替沙星治疗组。结果:在治疗后对两组患者治疗后的症状和临床疗效进行对比,采用莫西沙星治疗组在治疗后患者的痊愈率为81.25%,采用加替沙星治疗组的患者在治疗后的痊愈率为80.00%,莫西沙星治疗组的总有效率为98.75%,加替沙星治疗组的总有效率为97.50%,莫西沙星治疗组和加替沙星治疗组治疗期间不良反应的发生率均为10.00%,两组比较无显著性差异(p>0.05)。结论:莫西沙星与加替沙星在治疗女性尿路感染时有显著地疗效且不良反应的发生率低,可以广泛的应用于临床的治疗中。
OBJECTIVE: To compare and analyze the clinical efficacy of moxifloxacin and gatifloxacin in female urinary tract infection. Methods: 160 female patients diagnosed as urinary tract infection in our hospital from September 2012 to June 2013 were randomly divided into two groups: moxifloxacin group and gatifloxacin group. Results: After treatment, the symptoms and clinical efficacy of the two groups of patients were compared. The cure rate of the patients treated with moxifloxacin was 81.25%. The patients treated with gatifloxacin recovered after treatment The rate was 80.00%, the total effective rate of moxifloxacin group was 98.75%, the total effective rate of gatifloxacin group was 97.50%, the incidence of adverse reactions during the treatment of moxifloxacin group and gatifloxacin group Rates were 10.00%, no significant difference between the two groups (p> 0.05). Conclusion: Moxifloxacin and gatifloxacin are effective in treating urinary tract infection in women and the incidence of adverse reactions is low, which can be widely used in clinical treatment.